Full Text
PRS14 RISK-BENEFIT ASSESSMENT OF TELITHROMYCIN FOR THE TREATMENT OF CAP USING QUALITY-ADJUSTED DAYS (QAD) LOST

Abstract

Authors

LJ McGarry R Iskandar L Calimeris WS Dai JH Wu MC Weinstein

Back to Volume 8, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×